Only at Hinge Health

It’s not magic, it’s Enso

Enso is an FDA-cleared wireless device that relieves pain in minutes. So you can move with less pain and stay engaged in your recovery.

Relieves pain in minutes
Non-addictive, non-invasive
Works with your care plan
Pain relief in minutes
Enso

FDA-cleared

Pain relief in minutes

Patented waveforms deliver targeted pain relief across multiple body areas, including the back, knees, neck, shoulders, and more.

Wearable pain relief

Goes where you go

Small, wireless, and discreet. Use Enso at home, at work, or on the go, and control settings easily in the Hinge Health app.

Get help using Enso
Enso-Desktop and mobile-Scrolljack3-UI-310x230

1-on-1 support

Get help using Enso

Your care team can help you understand when to use Enso and how it fits into your care plan.

2.8x

more likely to reduce pain than exercise therapy alone ¹

1.6x

increase in mobility ²

0%

more exercises done by members with Enso ³

New!

Migraine relief is here

Your personalized program helps manage pain, symptoms, and triggers — with Enso for Migraine as part of your care.

Member using Enso Migraine

FAQs

  1. After 4 weeks, among users who consistently used their devices. Hong M, et al. Effectiveness of HFIT Compared to Traditional TENS in Patients with Chronic Low Back and Knee Pain. J Pain Res. 2024.
  2. In a placebo-controlled trial of 36 participants, after 4 weeks, on average. Amirdelfan K, et al. High-Frequency Impulse Therapy for Treatment of Chronic Back Pain: A Multicenter Randomized Controlled Pilot Study. J Pain Res. 2021.
  3. Hinge Health internal data, 2025.
  4. Among users who consistently used their devices, after 4 weeks. Hong M, et al. Effectiveness of Hybrid Form Impulse Therapy (HFIT) Compared to Traditional Transcutaneous Electronic Nerve Stimulation (TENS) in Patients with **TRUNCATED
  5. Compared to placebo users. In a trial of 36 participants, after 4 weeks, on average. Amirdelfan K, et al. High-Frequency Impulse Therapy for Treatment of Chronic Back Pain: A Multicenter Randomized Controlled Pilot Study. J Pain Res. 2021.